Interview: Mathieu Fitoussi, Country Manager, Servier, Poland
“Innovation is about bringing new chemical compounds on the market; but it is also, and sometimes even more, to continue the therapeutic development of the drugs which are already there”…
Address: Temapharm Ltd.
ul. Wigury Street 81
02-091 Warsaw ,Poland
Tel: +48 22 822 74 31
Web: http://www.temapharm.com/
Temapharm is a combination of a modern company with the best traditions of Polish medicine and pharmacy. We want to be a Polish doctor and pharmacist reliable and friendly partner for the Polish and the patient’s chance of recovery.
We are a Polish company focused on the Polish market. We want to focus on selected areas of pharmaceuticals and provide our partners the highest quality products. In our portfolio of medicines are four lines of therapeutic areas: respiratory medicine, psychiatry and neurology, oncology and gynaecology. Nasze products are manufactured in accordance with the applicable requirements of the European Union. Their production is held to the highest standards of quality GMP. The effectiveness of our products is confirmed bioequivalence study conducted among others by the leader in this industry – a Canadian company Anapharm.
respiratory medicine, psychiatry and neurology, oncology and gynaecology
“Innovation is about bringing new chemical compounds on the market; but it is also, and sometimes even more, to continue the therapeutic development of the drugs which are already there”…
Merck’s managing director discusses the importance of diversification to succeed in Poland by saying: “Nowadays, in such a dynamic environment the healthy level of diversification that Merck offers is becoming…
Medtronic’s country director brings some interesting perspectives on the differences between the pharma and medical device regulations in Poland by saying: “the medical device industry is discriminated against, as we…
The founder of PBA Consultancy offers a critical analysis of the new Reimbursement Act, looking at what could still be done to improve the system. Could you give us the…
The founder of PBA Consultancy offers a critical analysis of the new Reimbursement Act, looking at what could still be done to improve the system. Could you give us the…
The founder of PBA Consultancy offers a critical analysis of the new Reimbursement Act, looking at what could still be done to improve the system. Could you give us the…
Poland’s Main Pharmaceutical Inspector discusses the dangers behind falsified medicines and the need to control internet pharmacies. She also showcases the great power Poland holds as a manufacturing country with…
“In this very competitive environment, patents give companies an edge; this is why we must maintain innovative breakthroughs in our industry. This will then allow us to compete more efficiently…
“The overall Polish healthcare system is quite good. Of course, there are flaws, but Poland is equipped to treat almost any disease. The flaws in the system stem from historically…
In a world where diabetes increasingly more common, Poland has not been spared, with 2.5 million diabetic patients currently, and with a further 750,000 still unaware of their condition. In…
Cezary Sledziewski, Executive Director of PZPPF, discusses the pros and cons of Poland’s catching up with EU’s rising standards. He argues: “No one currently knows exactly how much these costs…
Polpharma , Poland’s role model and largest Polish manufacturer of drug products and active pharmaceutical ingredients, has pushed the Polish boundaries with the objective to become the fastest growing regional…
See our Cookie Privacy Policy Here
